292 related articles for article (PubMed ID: 6182668)
21. Quantitative enzymatic and immunologic computer-assisted histophotometry of human kidney tissue following neoplastic and other clinically significant alterations.
Heinert G; Scherberich J; Mondorf W; Weber W
Eur Urol; 1983; 9(4):235-41. PubMed ID: 6873127
[TBL] [Abstract][Full Text] [Related]
22. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Jotzoff M
Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
[TBL] [Abstract][Full Text] [Related]
23. Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07.
Humble MW; Bettelheim KA
N Z Med J; 1978 May; 87(612):366. PubMed ID: 353599
[No Abstract] [Full Text] [Related]
24. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
Adwan K; Abu-Hasan N; Al-Asmar H
J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
[TBL] [Abstract][Full Text] [Related]
25. Aminoglycoside resistance: a worldwide perspective.
Young LS; Hindler J
Am J Med; 1986 Jun; 80(6B):15-21. PubMed ID: 3089000
[TBL] [Abstract][Full Text] [Related]
26. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
[No Abstract] [Full Text] [Related]
27. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
[TBL] [Abstract][Full Text] [Related]
28. [Sensitivity in vitro of 192 Proteus strains to several aminoglycosides].
Thaller MC; Berchicchi R; Berlutti F; Maragoni F; Dainelli B
Ann Sclavo; 1981; 23(1):57-63. PubMed ID: 7294918
[TBL] [Abstract][Full Text] [Related]
29. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
Skalova R; Hajsig D; Babić I; Mostovac D
Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
[No Abstract] [Full Text] [Related]
30. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
Strausbaugh LJ; Mandaleris CD; Sande MA
J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
[TBL] [Abstract][Full Text] [Related]
32. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
De Broe ME; Giuliano RA; Verpooten GA
Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
Sato K; Matsumiya H; Saito A
Jpn J Antibiot; 1982 May; 35(5):1240-8. PubMed ID: 6813532
[TBL] [Abstract][Full Text] [Related]
34. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
Olier B; Morin JP; Thomas N; Fillastre JP
Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
[TBL] [Abstract][Full Text] [Related]
35. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
[TBL] [Abstract][Full Text] [Related]
36. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
Ling GV; Conzelman GM; Franti CE; Ruby AL
Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
[TBL] [Abstract][Full Text] [Related]
37. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
39. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Juhlin I; Tunevall G
Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
[TBL] [Abstract][Full Text] [Related]
40. Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.
Hottendorf GH; Gordon LL
Antimicrob Agents Chemother; 1980 Jul; 18(1):176-81. PubMed ID: 7416743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
